Back
LYFE SCIENCES
Project: HERA
NM_000535.7:c.1128A>C
p.Pro376=  ·  PMS2
Starting
Initialising…
0%
Legacy Engine
Processing…
Classification rationale
1

The PMS2 c.1128A>C (p.Pro376=) variant has been observed once in somatic cancers in COSMIC and has been reported in ClinVar predominantly as likely benign or benign by multiple single-submitter clinical laboratories.

clinvar ↗
2

This variant is present in gnomAD v2.1 and v4.1 at low frequency and is absent from gnomAD-Canada; the v4.1 allele frequency is 7.50e-05 (121/1612348 alleles) with a highest observed population frequency of 9.93e-05 in non-Finnish Europeans, which is above the PMS2 PM2_Supporting cutoff of 0.00002 but below the BS1 and BA1 population thresholds.

gnomad_v2 ↗ gnomad_v4 ↗ gnomad_canada ↗ cspec ↗
3

SpliceAI predicts no significant splice effect with a maximum delta score of 0.00, supporting BP4 and BP7 for this synonymous change.

spliceai ↗ cspec ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
—
—
Rationale
Select a criterion to inspect its explanation.
Evidence used
  • —
Gaps remaining
  • —
Rule
—
Publications
—
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1This variant is present in gnomAD v2.1 (AF= 3.58175e-05; MAF= 0.00358%, 9/251274 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 7.91431e-05; MAF= 0.00791%, 9/113718 alleles, homozygotes = 0); grpmax FAF= 4.115e-05.
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 7.50458e-05; MAF= 0.00750%, 121/1612348 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 9.92624e-05; MAF= 0.00993%, 117/1178694 alleles, homozygotes = 0); grpmax FAF= 8.433e-05.
gnomAD CanadaAbsent from gnomAD-Canada v1.0.
gnomAD v2 ↗ gnomAD v4 ↗ gnomAD 🇨🇦 ↗
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Likely benign (5 clinical laboratories) and as Likely Benign (2 clinical laboratories) and as Benign (1 clinical laboratory) and as likely benign (1 clinical laboratory). (ClinVarID = 135932)
ClinVar ↗
Functional evidence
03
Functional
OncoKB: Unknown Oncogenic Effect
OncoKB identified curated literature and non-variant-specific oncogenicity context for review; listed oncogenicity label: Unknown Oncogenic Effect.
OncoKB ↗
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
SpliceAI ↗
COSMIC evidence
05
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV56224632, n = 1 times).
COSMIC ↗
Cancer hotspots evidence
06
Cancer hotspots Not found
This variant does not lie in a statistically significant hotspot.
ResidueP376
Hotspots ↗